EP0842657A1
(de)
*
|
1996-11-19 |
1998-05-20 |
OctoPlus B.V. |
Mikrosphären zur gesteuerten Freisetzung und Verfahren zur Herstellung dieser Mikrosphären
|
FR2777895A1
(fr)
|
1998-04-28 |
1999-10-29 |
Debio Rech Pharma Sa |
Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
|
US6264991B1
(en)
*
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6656489B1
(en)
|
1999-02-10 |
2003-12-02 |
Isotis N.V. |
Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material
|
EP1038538A1
(de)
*
|
1999-03-19 |
2000-09-27 |
IsoTis B.V. |
Verfahren zur Regeneration von Muskelgewebe
|
DE60003803T2
(de)
|
1999-04-16 |
2004-06-03 |
Novo Nordisk A/S |
Trockene formbare arzneistoffformulierung
|
EP1068872A1
(de)
*
|
1999-07-12 |
2001-01-17 |
IsoTis B.V. |
Nahtmaterialen
|
AU4518400A
(en)
*
|
1999-07-12 |
2001-01-18 |
Isotis B.V. |
Sutures
|
WO2001010414A1
(en)
*
|
1999-08-04 |
2001-02-15 |
Oakwood Laboratories L.L.C. |
Slow release microspheres
|
AU769436B2
(en)
*
|
1999-08-06 |
2004-01-29 |
Chienna B.V. |
Molding of a polymer
|
EP1090928B1
(de)
*
|
1999-09-30 |
2004-05-26 |
Chienna B.V. |
Mit bioaktiven Mitteln beladene Polymeren
|
AU6132700A
(en)
|
1999-09-30 |
2001-04-05 |
Chienna B.V. |
Polymers loaded with bioactive agents
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
ATE355813T1
(de)
*
|
2000-07-14 |
2007-03-15 |
Novo Nordisk As |
Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
|
EP1247537A1
(de)
*
|
2001-04-04 |
2002-10-09 |
Isotis B.V. |
Beschichtung für medizinische Vorrichtungen
|
US7357947B2
(en)
*
|
2001-09-10 |
2008-04-15 |
Biomet, Inc. |
Bone graft material incorporating demineralized bone matrix and lipids
|
US6565884B2
(en)
|
2001-09-10 |
2003-05-20 |
Interpore Cross International |
Bone graft material incorporating demineralized bone matrix and lipids
|
AU2002343681B2
(en)
*
|
2001-11-12 |
2006-07-06 |
Alkermes Controlled Therapeutics, Inc. |
Biocompatible polymer blends and uses thereof
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
AU2002353661A1
(en)
*
|
2002-02-26 |
2003-09-09 |
Chienna B.V. |
Biodegradable polymeric material for biomedical applications
|
US7964207B2
(en)
*
|
2002-03-22 |
2011-06-21 |
Doctor's Research Group, Inc. |
Methods of performing medical procedures that promote bone growth, method of making compositions that promote bone growth, and apparatus for use in such methods
|
SI2561860T1
(en)
*
|
2002-05-31 |
2018-05-31 |
Titan Pharmaceuticals, Inc. |
An implantable polymeric device for prolonged release of buprenorphine
|
AU2003249244A1
(en)
*
|
2002-07-15 |
2004-02-02 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
US6926919B1
(en)
*
|
2003-02-26 |
2005-08-09 |
Advanced Cardiovascular Systems, Inc. |
Method for fabricating a coating for a medical device
|
US20050031667A1
(en)
|
2003-03-31 |
2005-02-10 |
Patel Rajesh A. |
Implantable polymeric device for sustained release of dopamine agonist
|
FR2861734B1
(fr)
|
2003-04-10 |
2006-04-14 |
Corneal Ind |
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
|
US20040215318A1
(en)
*
|
2003-04-24 |
2004-10-28 |
Brian Kwitkin |
Timed delivery of therapeutics to blood vessels
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
KR20070007086A
(ko)
|
2004-02-02 |
2007-01-12 |
암브룩스, 인코포레이티드 |
변형된 인간의 4 개의 나선형 다발 폴리펩티드 및 이의용도
|
CA2560507C
(en)
|
2004-03-26 |
2011-08-16 |
Surmodics, Inc. |
Composition and method for preparing biocompatible surfaces
|
NZ551335A
(en)
|
2004-06-18 |
2010-03-26 |
Ambrx Inc |
Antibodies and fragments thereof comprising an non naturally encoded amino acid coupled to a linker
|
WO2006002399A2
(en)
*
|
2004-06-24 |
2006-01-05 |
Surmodics, Inc. |
Biodegradable implantable medical devices, methods and systems
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
CA2569381A1
(en)
|
2004-07-21 |
2006-08-31 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
US7311980B1
(en)
*
|
2004-08-02 |
2007-12-25 |
Advanced Cardiovascular Systems, Inc. |
Polyactive/polylactic acid coatings for an implantable device
|
US20060073208A1
(en)
*
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
GB0426822D0
(en)
|
2004-12-07 |
2005-01-12 |
Precisense As |
Sensor for detection of glucose
|
GB0426823D0
(en)
|
2004-12-07 |
2005-01-12 |
Precisense As |
Sensor for detection of glucose
|
CN103520735B
(zh)
|
2004-12-22 |
2015-11-25 |
Ambrx公司 |
包含非天然编码的氨基酸的人生长激素配方
|
NZ584597A
(en)
|
2004-12-22 |
2011-09-30 |
Ambrx Inc |
Modified human growth hormone
|
MX2007007591A
(es)
|
2004-12-22 |
2007-07-25 |
Ambrx Inc |
Metodos para expresion y purificacion de hormona de crecimiento humano recombinante.
|
BRPI0519568C8
(pt)
*
|
2004-12-22 |
2022-06-14 |
Ambrx Inc |
Aminoacil-trna sintetase (rs), composições que compreendem a dita aminoacil-trna sintetase, célula de levedura, célula fúngica, célula não eucariótica, vetor que codifica uma rs, polinucleotídeo e ainda método para produzir um polipeptídeo em uma célula com um aminoácido selecionado em uma posição especificada
|
US20060147491A1
(en)
*
|
2005-01-05 |
2006-07-06 |
Dewitt David M |
Biodegradable coating compositions including multiple layers
|
US20060198868A1
(en)
*
|
2005-01-05 |
2006-09-07 |
Dewitt David M |
Biodegradable coating compositions comprising blends
|
EP1679065A1
(de)
*
|
2005-01-07 |
2006-07-12 |
OctoPlus Sciences B.V. |
Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis
|
CA2609205A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Ambrx, Inc. |
Improved human interferon molecules and their uses
|
EP1937824B1
(de)
|
2005-08-18 |
2013-03-13 |
Ambrx, Inc. |
trna-zusammensetzungen und deren verwendungen
|
NZ567234A
(en)
*
|
2005-11-08 |
2011-09-30 |
Ambrx Inc |
Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
|
DK2339014T3
(en)
*
|
2005-11-16 |
2015-07-20 |
Ambrx Inc |
Methods and compositions comprising non-natural amino acids
|
CA2629300C
(en)
|
2005-11-17 |
2014-07-08 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
SG10201405661QA
(en)
*
|
2005-12-14 |
2014-10-30 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
JP2009542671A
(ja)
*
|
2006-06-28 |
2009-12-03 |
サーモディクス,インコーポレイティド |
微粒子を含む活性剤溶出マトリックス
|
WO2008030558A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
KR20090052360A
(ko)
*
|
2006-09-08 |
2009-05-25 |
암브룩스, 인코포레이티드 |
척추동물 세포에서의 서프레서 tRNA 전사
|
US9133495B2
(en)
*
|
2006-09-08 |
2015-09-15 |
Ambrx, Inc. |
Hybrid suppressor tRNA for vertebrate cells
|
US20080138397A1
(en)
*
|
2006-10-24 |
2008-06-12 |
Aradigm Corporation |
Processes for taste-masking of inhaled formulations
|
WO2008073295A2
(en)
*
|
2006-12-07 |
2008-06-19 |
Surmodics, Inc. |
Latent stabilization of bioactive agents releasable from implantable medical articles
|
DK2068909T3
(da)
|
2007-03-30 |
2012-08-06 |
Ambrx Inc |
Modificerede FGF-21-polypeptider og anvendelse heraf
|
KR20100019467A
(ko)
|
2007-05-02 |
2010-02-18 |
암브룩스, 인코포레이티드 |
변형된 인터페론 베타 폴리펩티드 및 그의 용도
|
AU2008256819A1
(en)
|
2007-05-23 |
2008-12-04 |
Allergan, Inc. |
Cross-linked collagen and uses thereof
|
US20090022805A1
(en)
*
|
2007-06-28 |
2009-01-22 |
Joram Slager |
Polypeptide microparticles having sustained release characteristics, methods and uses
|
WO2009005709A1
(en)
*
|
2007-06-28 |
2009-01-08 |
Surmodics, Inc. |
Polypeptide microparticles
|
JP2010534681A
(ja)
*
|
2007-07-25 |
2010-11-11 |
バイオレックス・セラピューティクス インコーポレイテッド |
放出制御インターフェロン製剤及びそれを使用するhcv感染の治療
|
US8318695B2
(en)
|
2007-07-30 |
2012-11-27 |
Allergan, Inc. |
Tunably crosslinked polysaccharide compositions
|
US9138509B2
(en)
*
|
2007-09-14 |
2015-09-22 |
Musculoskeletal Transplant Foundation |
Composition for filling bone defects
|
US8697044B2
(en)
|
2007-10-09 |
2014-04-15 |
Allergan, Inc. |
Crossed-linked hyaluronic acid and collagen and uses thereof
|
EP2055299A1
(de)
|
2007-10-23 |
2009-05-06 |
Koninklijke Philips Electronics N.V. |
Verfahren zur Herstellung von Polymermikropartikeln
|
PL2818184T3
(pl)
|
2007-11-16 |
2019-06-28 |
Aclaris Therapeutics, Inc. |
Kompozycje i sposoby do leczenia plamicy
|
MX2010005317A
(es)
|
2007-11-20 |
2010-06-02 |
Ambrx Inc |
Polipeptidos de insulina modificados y sus usos.
|
US20090143348A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Ahmet Tezel |
Polysaccharide gel compositions and methods for sustained delivery of drugs
|
US8394782B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having increased longevity
|
US8394784B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having multi-stage bioactive agent delivery
|
DE102007062113B4
(de)
*
|
2007-12-21 |
2011-05-12 |
Bettina Lingenfelder |
Dermatologische Zubereitung
|
WO2009085550A1
(en)
*
|
2007-12-21 |
2009-07-09 |
3M Innovative Properties Company |
Retroreflective pavement markings
|
US9314524B2
(en)
*
|
2007-12-31 |
2016-04-19 |
Calla Therapeutics Llc |
Topical formulations of Flucytosine
|
CA2711490A1
(en)
*
|
2008-01-14 |
2009-07-23 |
Surmodics, Inc. |
Devices and methods for elution of nucleic acid delivery complexes
|
SG188143A1
(en)
|
2008-02-08 |
2013-03-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
WO2009120361A2
(en)
|
2008-03-28 |
2009-10-01 |
Surmodics, Inc. |
Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
|
US20090263449A1
(en)
*
|
2008-04-09 |
2009-10-22 |
Surmodics, Inc. |
Delivery of nucleic acid complexes from materials including negatively charged groups
|
US8496954B2
(en)
*
|
2008-04-18 |
2013-07-30 |
Surmodics, Inc. |
Coating systems for the controlled delivery of hydrophilic bioactive agents
|
EP3000462A1
(de)
|
2008-04-28 |
2016-03-30 |
Zogenix, Inc. |
Neuartige formulierungen zur behandlung von migräne
|
CA2723192A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Surmodics, Inc. |
Delivery of nucleic acid complexes from particles
|
US20100008966A1
(en)
*
|
2008-07-14 |
2010-01-14 |
Surmodics, Inc. |
Medical Devices and Methods for Delivery of Nucleic Acids
|
ES2654387T3
(es)
|
2008-07-23 |
2018-02-13 |
Ambrx, Inc. |
Polipéptidos G-CSF bovinos modificados y sus usos
|
US8450475B2
(en)
|
2008-08-04 |
2013-05-28 |
Allergan, Inc. |
Hyaluronic acid-based gels including lidocaine
|
ES2829971T3
(es)
|
2008-09-02 |
2021-06-02 |
Tautona Group Lp |
Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
|
WO2010031007A2
(en)
|
2008-09-12 |
2010-03-18 |
Genvault Corporation |
Matrices and media for storage and stabilization of biomolecules
|
NZ592249A
(en)
*
|
2008-09-26 |
2013-03-28 |
Ambrx Inc |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
UA106731C2
(uk)
|
2008-09-26 |
2014-10-10 |
Амбркс, Інк. |
Модифіковані поліпептиди еритропоетину тварин та їх застосування
|
EP2416762A2
(de)
*
|
2009-04-08 |
2012-02-15 |
SurModics, Inc. |
Vorrichtungen mit kontrollierter freisetzung und verfahren zur abgabe von nukleinsäuren
|
WO2010118213A2
(en)
|
2009-04-08 |
2010-10-14 |
Surmodics, Inc. |
Particles for delivery of nucleic acids and related devices and methods
|
US8246576B2
(en)
|
2009-05-18 |
2012-08-21 |
Surmodics, Inc. |
Method and apparatus for delivery of a therapeutic agent with an expandable medical device
|
AU2010341516B2
(en)
|
2009-12-21 |
2014-01-16 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
JP2013515081A
(ja)
|
2009-12-21 |
2013-05-02 |
アンブルックス,インコーポレイテッド |
修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用
|
US20110159098A1
(en)
*
|
2009-12-30 |
2011-06-30 |
Surmodics, Inc. |
Stabilization and delivery of nucleic acid complexes
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
KR101764451B1
(ko)
|
2010-03-12 |
2017-08-02 |
알러간 인더스트리 에스에이에스 |
피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
|
ES2729994T3
(es)
|
2010-03-22 |
2019-11-07 |
Allergan Inc |
Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
|
US20110319473A1
(en)
|
2010-06-29 |
2011-12-29 |
Surmodics, Inc. |
Compositions and methods for enhancement of nucleic acid delivery
|
EP2859887B1
(de)
|
2010-07-09 |
2017-03-22 |
InnoCore Technologies B.V. |
Biologisch abbaubare, phasengetrennte, segmentierte multiblock-copolymere und freisetzung von biologisch aktiven polypeptiden
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
PE20140160A1
(es)
|
2010-08-17 |
2014-02-08 |
Ambrx Inc |
Polipeptidos de relaxina modificados y sus usos
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8697057B2
(en)
|
2010-08-19 |
2014-04-15 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
WO2012042314A1
(en)
|
2010-10-02 |
2012-04-05 |
Link Research & Grants Corporation |
Treatment of tinnitus and related auditory dysfunctions
|
WO2012058274A2
(en)
|
2010-10-26 |
2012-05-03 |
Surmodics, Inc. |
Coatings and methods for controlled elution of hydrophilic active agents
|
US8901092B2
(en)
|
2010-12-29 |
2014-12-02 |
Surmodics, Inc. |
Functionalized polysaccharides for active agent delivery
|
US10213529B2
(en)
|
2011-05-20 |
2019-02-26 |
Surmodics, Inc. |
Delivery of coated hydrophobic active agent particles
|
US9861727B2
(en)
|
2011-05-20 |
2018-01-09 |
Surmodics, Inc. |
Delivery of hydrophobic active agent particles
|
FR2975301B1
(fr)
|
2011-05-20 |
2013-05-24 |
Flamel Tech Sa |
Composition comprenant un interferon alpha
|
US9393263B2
(en)
|
2011-06-03 |
2016-07-19 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US20130096081A1
(en)
|
2011-06-03 |
2013-04-18 |
Allergan, Inc. |
Dermal filler compositions
|
US9408797B2
(en)
|
2011-06-03 |
2016-08-09 |
Allergan, Inc. |
Dermal filler compositions for fine line treatment
|
EP2714002B1
(de)
|
2011-06-03 |
2019-04-03 |
Allergan, Inc. |
Dermale füllstoffzusammensetzungen mit antioxidantien
|
EP2734843A2
(de)
|
2011-07-18 |
2014-05-28 |
President and Fellows of Harvard College |
Manipulierte moleküle zur anzielung von mikroben und ihre verwendungen
|
AU2012287577B2
(en)
|
2011-07-22 |
2017-02-16 |
InnoCore Technologies Holding B.V. |
Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
|
US20130244943A1
(en)
|
2011-09-06 |
2013-09-19 |
Allergan, Inc. |
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
|
US9662422B2
(en)
|
2011-09-06 |
2017-05-30 |
Allergan, Inc. |
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
|
US9738724B2
(en)
|
2012-06-08 |
2017-08-22 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
EP3135690A1
(de)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modifizierte fc-proteine mit stellenspezifischen nichtnatürlichen aminosäureresten, konjugate daraus, verfahren zu deren herstellung und verfahren zu deren verwendung
|
PL2890402T3
(pl)
|
2012-08-31 |
2019-08-30 |
Sutro Biopharma, Inc. |
Modyfikowane aminokwasy zawierające grupę azydkową
|
US11246963B2
(en)
|
2012-11-05 |
2022-02-15 |
Surmodics, Inc. |
Compositions and methods for delivery of hydrophobic active agents
|
JP6438406B2
(ja)
|
2012-11-05 |
2018-12-12 |
サーモディクス,インコーポレイテッド |
疎水性生理活性物質を送達するための組成物および方法
|
WO2014167440A1
(en)
|
2013-03-26 |
2014-10-16 |
Wockhardt Limited |
Modified release pharmaceutical compositions of cyclobenzaprine or salts thereof
|
EP3848045A1
(de)
|
2013-05-21 |
2021-07-14 |
President and Fellows of Harvard College |
Manipulierte hämbindende zusammensetzungen und verwendungen davon
|
FR3007972B1
(fr)
|
2013-07-04 |
2015-08-07 |
Oreal |
Composition cosmetique comprenant des esters gras liquides, des huiles volatiles et des epaississants, et procede de traitement cosmetique
|
EP3019522B1
(de)
|
2013-07-10 |
2017-12-13 |
Sutro Biopharma, Inc. |
Antikörper mit mehreren ortsspezifischen nichtnatürlichen aminosäureresten, verfahren zu deren herstellung und verfahren zu deren verwendung
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
WO2015150948A1
(en)
|
2014-03-29 |
2015-10-08 |
Wockhardt Limited |
Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof
|
WO2016040347A2
(en)
|
2014-09-08 |
2016-03-17 |
University Of Iowa Research Foundation |
Microrna inhibitor system and methods of use thereof
|
US10722444B2
(en)
|
2014-09-30 |
2020-07-28 |
Allergan Industrie, Sas |
Stable hydrogel compositions including additives
|
EA036697B1
(ru)
|
2014-10-24 |
2020-12-09 |
Бристол-Майерс Сквибб Компани |
Модифицированные полипептиды fgf-21 и их применение
|
WO2016128783A1
(en)
|
2015-02-09 |
2016-08-18 |
Allergan Industrie Sas |
Compositions and methods for improving skin appearance
|
CA2986702C
(en)
|
2015-05-21 |
2023-04-04 |
David Wang |
Modified demineralized cortical bone fibers
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
US10273476B2
(en)
|
2016-04-30 |
2019-04-30 |
University Of Iowa Research Foundation |
MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
|
RU2617049C1
(ru)
*
|
2016-05-12 |
2017-04-19 |
Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" |
Противоопухолевое лекарственное средство на основе никлозамида
|
US10898446B2
(en)
|
2016-12-20 |
2021-01-26 |
Surmodics, Inc. |
Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
|
EP3580232B1
(de)
|
2017-02-08 |
2023-09-20 |
Bristol-Myers Squibb Company |
Modifizierte relaxin-polypeptide mit einem pharmakokinetischen verstärker und deren verwendungen
|
EP3728296A1
(de)
|
2017-12-20 |
2020-10-28 |
Allergan, Inc. |
Polypeptide der botulinumtoxin-zellbindungsdomäne und verfahren zur verwendung zur hautverjüngung
|
US12049485B2
(en)
|
2018-09-11 |
2024-07-30 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
CN113366015A
(zh)
|
2018-10-19 |
2021-09-07 |
Ambrx公司 |
白细胞介素-10多肽缀合物、其二聚体及其用途
|
BR112021015832A2
(pt)
|
2019-02-12 |
2022-01-18 |
Ambrx Inc |
Composições que contêm conjugados de anticorpo-agonista de tlr, métodos e usos dos mesmos
|
IL296099A
(en)
|
2020-03-11 |
2022-11-01 |
Ambrx Inc |
Interleukin-2 polypeptide conjugates and methods of using them
|
KR20230073200A
(ko)
|
2020-08-20 |
2023-05-25 |
암브룩스, 인코포레이티드 |
항체-tlr 작용제 접합체, 그 방법 및 용도
|
JP2024512775A
(ja)
|
2021-04-03 |
2024-03-19 |
アンブルックス,インコーポレイテッド |
抗her2抗体薬物コンジュゲート及びその使用
|